Mrs Linda J Rawlings, LMHC | |
60 Merrimack St, Haverhill, MA 01830-6207 | |
(978) 373-1126 | |
(978) 373-6363 |
Full Name | Mrs Linda J Rawlings |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 60 Merrimack St, Haverhill, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063553162 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 5366 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Linda J Rawlings, LMHC 60 Merrimack St, Haverhill, MA 01830-6207 Ph: (978) 373-1126 | Mrs Linda J Rawlings, LMHC 60 Merrimack St, Haverhill, MA 01830-6207 Ph: (978) 373-1126 |
News Archive
A team led by Michael Trauner at MedUni Vienna's Division of Gastroenterology and Hepatology demonstrated the beneficial effect of synthetically produced bile acid with the active agent nor-ursodeoxycholic acid (nor-urso) in the hitherto incurable liver disease primary sclerosing cholangitis (PSC) around two years ago.
NETTER-1 study, showing clinically meaningful and significant results for Lutathera (77Lu-DOTA0-Tyr3-Octreotate) in patients with metastatic midgut neuroendocrine tumors (NETs). The data will be presented Monday, June 6, during the American Society of Clinical Oncology Annual Meeting in Chicago.
The philanthropic organization Dubai Cares has announced a $1 million donation to partner with The END Fund in the establishment "of a school-based deworming program that will treat children in Angola," according to the Global Network for Neglected Tropical Diseases' (NTD) "End the Neglect" blog.
A survey of women undergoing routine screening mammography found that many of them would be interested in pursuing additional screening tests if notified they had dense breast tissue, despite the possibility of false positives, invasive procedures, and out-of-pocket costs, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Novartis and the Drugs for Neglected Diseases initiative, a not-for-profit research and development organization, have signed a collaboration and license agreement to jointly develop LXE408, as a potential new oral treatment for visceral leishmaniasis, one of the world's leading parasitic killers.
› Verified 4 days ago
Jennifer Simard, Counselor Medicare: Not Enrolled in Medicare Practice Location: 60 Merrimack St, Haverhill, MA 01830 Phone: 978-373-1126 Fax: 978-373-6363 | |
Laura Ann Hanaford, M.ED, LMHC, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 57 Wingate St Unit 401, Haverhill, MA 01832 Phone: 978-241-4908 | |
Samantha Asmar, Counselor Medicare: Not Enrolled in Medicare Practice Location: 26 Parkridge Rd, Haverhill, MA 01835 Phone: 978-380-0825 | |
Desirae Messina, Counselor Medicare: Not Enrolled in Medicare Practice Location: 26 Parkridge Rd Ste 2b, Haverhill, MA 01835 Phone: 978-374-0414 | |
Frank Joseph Saracino, Counselor Medicare: Not Enrolled in Medicare Practice Location: 60 Merrimack St, Haverhill, MA 01830 Phone: 978-373-1126 Fax: 978-373-6363 | |
Amanda L Cole, Counselor Medicare: Not Enrolled in Medicare Practice Location: 116 Summer St, Haverhill, MA 01830 Phone: 978-373-7010 | |
Ryan Paradise, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 60 Merrimack St, Haverhill, MA 01830 Phone: 978-373-1126 Fax: 978-373-6363 |